Effects of roxithromycin, erythromycin and troleandomycin on their N-demethylation by rat and human cytochrome P450 enzymes

References

• Bailey D. G. Food-drug interactions: emphasis on grapefruit juice effects. Canadian Journal of Clinical Pharmacology 1995; 2: 10–14
   Google Scholar
• Bailey D. G., Arnold J. M. O., Bend J. R., Tran L. T., Spence J. D. Grapefruit juice—felodipine interaction: reproducibility and characterization with the extended release drug formulation. British Journal of Clinical Pharmacology 1995; 40: 135–140
   PubMed Web of Science ®Google Scholar
• Birkett D. J., Robson R. A., Grgurinovich N., Tonkin A. Single oral dose pharmaco-kinetics of erythromycin and roxithromycin and the effects of chronic dosing. Therapeutic Drug Monitoring 1990; 12: 65–71
   PubMed Web of Science ®Google Scholar
• Bossche H. V., Koymans L., Moereels H. P450 inhibitors of use in medical treatment: focus on mechanisms of action. Pharmacology and Therapeutics 1995; 67: 79–100
   PubMed Web of Science ®Google Scholar
• Coutts R. T., Su P., Baker G. B. Involvement of CYP2D6, CYP3A4, and other cytochrome P-450 isozymes in N-dealkylation reactions. Journal of Pharmacological and Toxicological Methods 1994; 31: 177–186
   PubMed Web of Science ®Google Scholar
• Delaforge M., Sartori E., Mansuy D. In vivo and in vitro effects of a new macrolide antibiotic roxithromycin on rat liver cytochrome P-450: comparison with troleandomycin and erythromycin. Chemico-Biological Interactions 1988; 68: 179–188
   PubMedGoogle Scholar
• Gillam E., Baba T., Kim B. R., Ohmori S., Guengerich F. P. Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. Archives of Biochemistry and Biophysics 1993; 305: 123–131
   PubMed Web of Science ®Google Scholar
• Gillum J. G., Israel D. S., Polk R. E. Pharmacokinetic drug interactions with antimicrobial agents. Clinical Pharmacokinetics 1993; 25: 450–482
   PubMedGoogle Scholar
• Gonzalez F. J. Molecular genetics of the P-450 superfamily. Pharmacology and Therapeutics 1990; 45: 1–38
   PubMed Web of Science ®Google Scholar
• Guengerich F. P. Analysis and characterization of enzymes. Principles and Methods of Toxicology, A. W. Hayes. Raven, New York 1994; 1259–1313
   Google Scholar
• Guengerich F. P., Martin M. V., Beaune P. H., Kremers P., Wolff T., Waxman D. J. Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. Journal of Biological Chemistry 1986; 261: 5051–5060
   PubMed Web of Science ®Google Scholar
• Guengerich F. P., Shimada T. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chemical Research in Toxicology 1991; 4: 391–407
   PubMed Web of Science ®Google Scholar
• Guengerich F. P., Wang P., Davidson N. K. Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Biochemistry 1982; 21: 1698–1706
   PubMed Web of Science ®Google Scholar
• Ha H. R., Chen J., Leuenberger P. M., Freiburghaus A. U., Follath F. In vitro inhibition of midazolam and quinidine metabolism by flavonoids. European Journal of Clinical Pharmacology 1995; 48: 367–371
   PubMed Web of Science ®Google Scholar
• Honig P. K., Wortham D. C., Zamani K., Conner D. P., Mullin J. C., Cantilena L. R. Terfenadine—ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences. Journal of the American Medical Association 1993; 269: 1513–1518
   PubMed Web of Science ®Google Scholar
• Imai Y. The roles of cytochrome-b5 in reconstituted monooxygenase systems containing various forms of hepatic microsomal cytochrome P-450. Journal of Biochemistry 1981; 89: 351–362
   PubMed Web of Science ®Google Scholar
• Imaoka S., Fujita S., Funae Y. Age-dependent expression of cytochrome P-450s in rat liver. Biochimica et Biophysica Acta 1991; 1097: 187–192
   PubMed Web of Science ®Google Scholar
• Imaoka S., Terano Y., Funae Y. Constitutive testosterone 6β-hydroxylase in rat liver. Journal of Biochemistry 1988; 104: 481–487
   PubMed Web of Science ®Google Scholar
• Kaminsky L. S., Fasco M. J., Guengerich F. P. Production and application of antibodies to rat liver cytochrome P-450. Methods in Enzymology 1981; 74: 262–272
   PubMedGoogle Scholar
• Ketterer T. A., Flockhart D. A., Post R. M., Denicoff K., Pazzaglla P. J., Marangell L. B., George M. S., Callahan A. M. The emerging role of cytochrome P450 3A in psychopharmacology. Journal of Clinical Psychopharmacology 1995; 15: 387–398
   PubMedGoogle Scholar
• Kivistö K. T., Kroemer H. K., Eichelbaum M. The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions. British Journal of Clinical Pharmacology 1995; 40: 523–530
   PubMed Web of Science ®Google Scholar
• Kocarek T. A., Schuetz E. G., Strom S. C., Fisher R. A., Guzelian P. S. Comparative analysis of cytochrome P4503A induction in primary cultures of rat, rabbit, and human hepatocytes. Drug Metabolism and Disposition 1995; 23: 415–421
   PubMed Web of Science ®Google Scholar
• Larrey D., Funck-Brentano C., Breil P., Vitaux J., Theodore C., Babany G., Pessayre D. Effects of erythromycin on hepatic drug metabolising enzymes in humans. Biochemical Pharmacology 1983; 32: 1063–1068
   PubMed Web of Science ®Google Scholar
• Levy R. H. Cytochrome P450 isozymes and antiepileptic drug interactions. Epilepsia 1995; 36: S8–13
   PubMed Web of Science ®Google Scholar
• Li A. P., Rasmussen A., Xu L., Kaminski D. L. Rifampicin induction of lidocaine metabolism in cultured human hepatocytes. Journal of Pharmacology and Experimental Therapeutics 1995; 274: 673–677
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Mäenpää J., Pelkonen O., Cresteil T., Rane A. The role of cytochrome P450 3A (CYP3A) isoform(s) in oxidative metabolism of testosterone and benzphetamine in human adult and fetal liver. Journal of Steroid Biochemistry and Molecular Biology 1993; 44: 61–67
   PubMed Web of Science ®Google Scholar
• Nash T. The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochemical Journal 1953; 55: 416–421
   PubMed Web of Science ®Google Scholar
• Omura T., Sato R. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry 1964; 239: 2370–2378
   PubMed Web of Science ®Google Scholar
• Periti P., Mazzei T., Mini E., Novelli A. Pharmacokinetic drug interactions of macrolides. Clinical Pharmacokinetics 1992; 23: 106–131
   PubMed Web of Science ®Google Scholar
• Robinson R. C., Nagata K., Gelboin H. V., Rifkind J., Gonzalez F. J., Friedman F. K. Developmental regulation of hepatic testosterone hydroxylases: simultaneous activation and repression of constitutively expressed cytochromes P450 in senescent rats. Archives of Biochemistry and Biophysics 1990; 277: 42–46
   PubMedGoogle Scholar
• Shimada T., Iwasaki M., Martin M. V., Guengerich F. P. Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA1535/pSK1002. Cancer Research 1989; 49: 3218–3228
   PubMed Web of Science ®Google Scholar
• Shimada T., Nakamura S. Cytochrome P-450-mediated activation of procarcinogens and promutagens to DNA-damaging products by measuring expression of umu gene in Salmonella typhimurium TA1535/pSK1002. Biochemical Pharmacology 1987; 36: 1979–1987
   PubMed Web of Science ®Google Scholar
• Shimada T., Nakamura S., Imaoka S., Funae Y. Genotoxic and mutagenic activation of aflatoxin B1 by constitutive forms of cytochrome P-450 in rat liver microsomes. Toxicology and Applied Pharmacology 1987; 91: 13–21
   PubMed Web of Science ®Google Scholar
• Shimada T., Yamazaki H., Mimura M., Inui Y., Guengerich F. P. Interindividual variations in human liver cytochrome P-450 enzvmes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics 1994; 270: 414–423
   PubMed Web of Science ®Google Scholar
• Taniguchi H., Imai Y., Inyanagi T., Sato R. Interaction between NADPH-cytochrome P-450 reductase and cytochrome P-450 in the membrane of phosphatidylcholine vesicles. Biochimica et Biophysica Acta 1979; 550: 341–356
   PubMed Web of Science ®Google Scholar
• Upton R. A. Pharmacokinetic interactions between theophylline and other medication (Part I). Clinical Pharmacokinetics 1991; 20: 66–80
   PubMed Web of Science ®Google Scholar
• Watkins P. B., Turgeon D. K., Saenger P., Lown K. S., Kolars J. C., Hamilton T., Fishman K., Guzelian P. S., Voorhees J. J. Comparison of urinary 6-β-cortisol and the erythromycin breath test as measures of hepatic P450IIIa (CYP3A) activity. Clinical Pharmacology and Therapeutics 1992; 52: 265–273
   PubMed Web of Science ®Google Scholar
• Wrighton S. A., Ring B. J., Vandenbranden M. The use of in vitro metabolism techniques in the planning and interpretation of drug safety studies. Toxicology and Pathology 1995; 23: 199–208
   PubMed Web of Science ®Google Scholar
• Wrighton S. A., Stevens J. C. The human hepatic cytochromes P450 involved in drug metabolism. Critical Reviews in Toxicology 1992; 22: 1–21
   PubMed Web of Science ®Google Scholar
• Yamazaki H., Guo Z., Persmark M., Mimura M., Inoue K., Guengerich F. P., Shimada T. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes. Molecular Pharmacology 1994; 46: 568–577
   PubMed Web of Science ®Google Scholar
• Yamazaki H., Nakano M., Imai Y., Ueng Y.-F., Guengerich F. P., Shimada T. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes. Archives of Biochemistry and Biophysics 1996; 325: 174–182
   PubMed Web of Science ®Google Scholar
• Yasukochi Y., Masters B. Some properties of a detergent-solubilized NADPH-cytochrome c (cytochrome P-450) reductase purified by biospecific affinity chromatography. Journal of Biological Chemistry 1976; 251: 5337–5344
   PubMed Web of Science ®Google Scholar